Drugs / 18F-LY3950321
last change Apr 2023 re-read 3 minutes ago

18F-LY3950321

Diagnostic / imaging agent

Investigated by
Avid Radiopharmaceuticals

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT05775601 Feb → Apr 2023 — Avid Radiopharmaceuticals Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as 18F-LY3950321 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05775601 ↗
Modality Diagnostic / imaging agent “positron emission tomography (PET) tracer” NCT05775601 ↗